Lightnews — Scholar-powered news

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 1d

Hi Norma, your kind words about your experience at Cedars-Sinai Cancer are very much appreciated! Thank you for sharing your experience with us.

1 1 1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 1d

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support.
jobs.cshs.org#en/sites/CX_...

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 1d

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.

Reposted by Cedars-Sinai Cancer

The Cancer Letter @cancerletter.com · 2d

Alessio Pigazzi, expert in robot-assisted techniques, selected as new colorectal surgery leader at Cedars-Sinai (@cedarssinaicancer.bsky.social)
https://cancerletter.com/in-brief/20251003_8c/

https://cancerletter.com/in-brief/20251003_8c/

No description found

cancerletter.com

1 1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 2d

The Cedars-Sinai Cancer: Adolescents and Young Adult Cancer Conference will take place on 10/11 at the Marina Del Rey Marriott with updates on best practices for multi-disciplinary management of adolescent and young adult cancer.
cedars.cloud-cme.com/course/cours...

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 2d

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 6d

Our fourth cohort of Undergraduates Gaining Research Opportunities for the Cancer Workforce (U-GROW) Program research internships was completed this summer! Congratulations to all of the promising young researchers!

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 6d

We’ re proud our Cancer Research Training and Education Coordination Office in partnership with YMCA Metro LA held the Beyond the Books: High School Healthcare Career Exploration Program this summer with 24 high school students learning about cancer research!

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 6d

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support.
jobs.cshs.org#en/sites/CX_...

2

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 8d

Check the latest cancer-related publications from Cedars-Sinai and Cedars-Sinai Cancer clinicians and researchers! Follow this link on LinkedIn for a listing of these cutting-edge research papers.
www.linkedin.com/posts/cedars...

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 8d

Cedars-Sinai Cancer clinicians and researchers are sharing their expertise in a variety of interviews and articles on a wide range of topics! Follow this link on LinkedIn to see the latest news on their work.
www.linkedin.com/pulse/cedars...

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 9d

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Reposted by Cedars-Sinai Cancer

Lisa MG, RN @lmg622.bsky.social · 19d

What is the prevalence of #BRCA pathogenic or likely (P/LP) variants in an unselected population of women with #breastcancer? Via @jamanetworkopen.com @cedarssinaicancer.bsky.social

#hereditarycancer #BCSM #womenshealth #genetics #cancerresearch #medsky

BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer

This cohort study examines the prevalence of pathogenic or likely pathogenic variants in BRCA1 and BRCA2 in women with breast cancer in a racially and ethnically diverse population.

jamanetwork.com

1 4

Reposted by Cedars-Sinai Cancer

Sandy Anderson @sandyanderson.bsky.social · 13d

Fab closing presentation by friend and #mathonco agitator @gliomath.bsky.social from @cedarssinaicancer.bsky.social presenting cool new work, Every Patient Deserves Their Own Equation: Towards Digital Twins for Neuro-Oncology.

1 2 4

Reposted by Cedars-Sinai Cancer

American Association for Cancer Research (AACR) @theaacr.bsky.social · 15d

ER-positive, HER2-negative is the most common subtype of breast cancer. Learn more about prevention, screening, and treatment options for breast: buff.ly/dYFDLF1

Breast Cancer Overview - American Association for Cancer Research (AACR)

More than 250,000 women a year are diagnosed with breast cancer in the U.S. Learn about the prevention, screening, and treatment options for breast cancer.

www.aacr.org

2 2

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 15d

We are proud to have Cedars Sinai recognized in the Honor Roll of the U.S. News & World Report's Annual "Best Hospitals" Rankings for the 10th consecutive year and tied for #1 in California and #1 in Los Angeles! @usnews.com
www.cedars-sinai.org/newsroom/ced...

Image of Cedars-Sinai hospital and US News Honor Roll badge as Top US Hospital for 10th consecutive year

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 15d

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 17d

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support.
jobs.cshs.org#en/sites/CX_...

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 17d

Cedars-Sinai Cancer clinicians and researchers will be at The American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting 9/27-10/1! See the highlight schedule for their presentations and activities at the meeting. @astro-org.bsky.social #ASTRO25

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 17d

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.
clinicaltrials.cedars-sinai.edu/view/IIT2022...

1 1

Reposted by Cedars-Sinai Cancer

The Cancer Letter @cancerletter.com · 22d

Ze’ev Ronai, MD: "We simply did not realize how important the environment is for tumor development and the enormous role played by immune responses and the tumor microenvironment."
https://cancerletter.com/guest-editorial/20250912_2/

Reflections of a cancer scientist Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - The Cancer Letter

What inspires us? What gets us excited? What causes us to devote our life to a cause? The unknown, a hope for better options, the drive to discover. Example? Look at where our understanding of cancer was two, five, 10, 15, 20, or more years ago and then consider what has happened over the past […]

cancerletter.com

1 1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 24d

Dr. Vladimir Ljubimov is first author on the Journal of Controlled Release paper describing a new therapeutic system developed with the help of AI that significantly improved survival of laboratory mice with primary central nervous system lymphoma.
www.cedars-sinai.org/newsroom/ai-...

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 24d

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 24d

The International Association for the Study of Lung Cancer @iaslc.bsky.social Lung Cancer News covered the results of the Phase III Pragmatica-Lung trial presented at the 2025 ASCO @ascocancer.bsky.social annual meeting by Dr. Karen Reckamp.
www.ilcn.org/a-pragmatic-...

1

Cedars-Sinai Cancer @cedarssinaicancer.bsky.social · 24d

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.
clinicaltrials.cedars-sinai.edu/view/IIT2022...